The canonical FGF-FGFR signaling system at the molecular level
Authors
Patrycja Szybowska
Department of Tumor Biology Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Montebello, Norway
Center for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Montebello, Norway
Ellen Margrethe Haugsten
Department of Tumor Biology Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Montebello, Norway
Center for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Montebello, Norway
Antoni Wiedlocha
antoni.wiedlocha@ous-research.no
Department of Molecular Cell Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Montebello, Norway
Center for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Montebello, Norway
Military Institute of Hygiene and Epidemiology, Warsaw, Poland
DOI: https://doi.org/10.2478/ahem-2021-0024 | Journal eISSN: 1732-2693
Language: English
Page range: 711 - 719
Submitted on: Oct 16, 2020
Accepted on: Feb 24, 2021
Published on: Jan 17, 2022
Published by: Hirszfeld Institute of Immunology and Experimental Therapy
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
Related subjects:
© 2022 Patrycja Szybowska, Ellen Margrethe Haugsten, Antoni Wiedlocha, published by Hirszfeld Institute of Immunology and Experimental Therapy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.